3/24/2023  5:35:54 PM Chg. -0.20 Volume Bid3/24/2023 Ask3/24/2023 Market Capitalization Dividend Y. P/E Ratio
52.60EUR -0.38% 15,842
Turnover: 828,870.90
-Bid Size: - -Ask Size: - 2.91 bill.EUR - -

Business description

BB Biotech invests in companies in the fast growing market of biotechnology and is one of the world’s largest investors in this sector. BB Biotech is listed in Switzerland, Germany and Italy. Its investments are focused on listed companies that are developing and commercializing novel medical treatments and cures. BB Biotech’s investment selection process is guided by the fundamental research and analysis of physicians and molecular biologists. Its Board of Directors has many years of experience in industry and science.

Management board & Supervisory board

Dr. Daniel Koller
Management board
Dallas Webb, Dr. Christian Koch, Dr. Maurizio Bernasconi, Dr. Samuel Croset, Dr. Stephen Taubenfeld, Felicia Flanigan
Supervisory board
Dr. Erich Hunziker, Dr. Clive Meanwell, Dr. Thomas von Planta, Prof. Dr. Mads Krogsgaard Thomsen

Company data

Name: BB Biotech AG
Address: Schwertstraße 6,CH-8200 Schaffhausen/Schweiz
Phone: +41-52-624-0845
Fax: -
E-mail: info@bbbiotech.com
Internet: www.bbbiotech.com
Industry: Financial
Sector: Specialty Finance
Sub sector: Diversified Financial
End of financial year: 12/31
Free Float: 96.47%
IPO date: 12/10/1997

Investor relations

Name: Dr. Silvia Siegfried-Schanz
IR phone: +41-44-267-7266
IR Fax: -
IR e-mail: ssc@bellevue.ch

Company calendar

CW 13 | 3/28/2023 4th Quarter/Annual Report
CW 19 | 5/11/2023 Interim Report 1st Quarter/3 Months
CW 22 | 5/31/2023 General Shareholder Meeting
CW 32 | 8/10/2023 Interim Report 2nd Quarter/6 Months
CW 46 | 11/14/2023 Interim Report 3rd Quarter/9 Months

Main Shareholders

Lazard Asset Management LLC, New York, USA